Pub Date : 2025-12-16eCollection Date: 2025-01-01DOI: 10.2147/IJWH.S561704
Dilay Gök Korucu, Şükran Doğru, Fatih Akkuş, Huriye Ezveci, Ülfet Sena Metin, Kazım Gezginc
Purpose: This study was conducted to evaluate the effects of epilepsy on pregnancy and delivery outcomes. It aimed to assess the relationship of seizure type, the presence of seizures during pregnancy, and the timing of the last seizure before conception on perinatal outcomes for pregnant women with epilepsy (WWE).
Methods: The research included 300 participants, comprising 100 pregnant WWE and a control group of 200 healthy pregnant women. The study analyzed demographic and clinical data for all subjects. Perinatal outcomes were evaluated according to seizure type, seizure status during pregnancy, and the last seizure before pregnancy.
Results: The results showed a high rate of cesarean sections in the epilepsy group, at 71%. The number of babies born small for gestational age (SGA) was also significantly higher among WWE (p = 0.001). While there was no significant difference in most maternal and fetal outcomes between women with generalized and non-generalized seizures, the study identified pre-conception presence of seizures as a critical factor. Women who had experienced a seizure within the year before becoming pregnant had babies born at an earlier gestational week (p = 0.021) and with a lower birth weight (p = 0.018) compared to those whose last seizure was more than a year ago. Furthermore, 45% of the WWE had seizures during their pregnancy.
Conclusion: The most important predictor of seizures during pregnancy is the presence of seizures before pregnancy. Presence of seizures during gestation is strongly associated with adverse perinatal outcomes, whereas the specific type of epilepsy is not.
{"title":"The Effect of Seizures on Perinatal Outcomes in Pregnant Women with Epilepsy: A Single Center Retrospective Study.","authors":"Dilay Gök Korucu, Şükran Doğru, Fatih Akkuş, Huriye Ezveci, Ülfet Sena Metin, Kazım Gezginc","doi":"10.2147/IJWH.S561704","DOIUrl":"10.2147/IJWH.S561704","url":null,"abstract":"<p><strong>Purpose: </strong>This study was conducted to evaluate the effects of epilepsy on pregnancy and delivery outcomes. It aimed to assess the relationship of seizure type, the presence of seizures during pregnancy, and the timing of the last seizure before conception on perinatal outcomes for pregnant women with epilepsy (WWE).</p><p><strong>Methods: </strong>The research included 300 participants, comprising 100 pregnant WWE and a control group of 200 healthy pregnant women. The study analyzed demographic and clinical data for all subjects. Perinatal outcomes were evaluated according to seizure type, seizure status during pregnancy, and the last seizure before pregnancy.</p><p><strong>Results: </strong>The results showed a high rate of cesarean sections in the epilepsy group, at 71%. The number of babies born small for gestational age (SGA) was also significantly higher among WWE (p = 0.001). While there was no significant difference in most maternal and fetal outcomes between women with generalized and non-generalized seizures, the study identified pre-conception presence of seizures as a critical factor. Women who had experienced a seizure within the year before becoming pregnant had babies born at an earlier gestational week (p = 0.021) and with a lower birth weight (p = 0.018) compared to those whose last seizure was more than a year ago. Furthermore, 45% of the WWE had seizures during their pregnancy.</p><p><strong>Conclusion: </strong>The most important predictor of seizures during pregnancy is the presence of seizures before pregnancy. Presence of seizures during gestation is strongly associated with adverse perinatal outcomes, whereas the specific type of epilepsy is not.</p>","PeriodicalId":14356,"journal":{"name":"International Journal of Women's Health","volume":"17 ","pages":"5509-5519"},"PeriodicalIF":2.6,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12717958/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: Premature ovarian insufficiency (POI) is a common late effect of chemotherapy among survivors of adolescent and young-adult cancer (AYAC). Given on the widespread use of Chinese herbal medicine (CHM) in restoring individual health, we performed a cohort-based nested patient-control study with the aim of exploring the effect of blending CHM into routine care on the reduction of chemotherapy-induced POIrisk among females with AYAC.
Methods: Females aged 20-39 years with a newly-diagnosed AYAC and being free of POI between 2002 and 2010 were recruited from a population-based claims data. From these enrollees, we identified those with POI occurring after AYAC onset by the end of 2013 (n = 1040). Corresponding controls were randomly selected from the remaining subjects using a pair-matched approach. We then adopted conditional logistic regression to clarify the association between CHM use and POI risk, shown as 95% confidence intervals (CI) and adjusted odds ratios (AOR).
Results: Patients who revived CHM in addition to standard treatment towards AYAC experienced a substantial lower risk of POI than did those who did not use CHM (AOR, 0.16; 95% CI, 0.13-0.19). Importantly, initiating CHM treatment within the first three years after AYAC onset had the greatest benefit, with a lower risk of POI by 92%.
Conclusion: The present study revealed that embedding CHM into routine care of AYAC acted to prevent subsequent POI incident, implying that interdisciplinary collaboration and timely treatment planning should be emphasized to reduce the chance of POI onset.
{"title":"Mitigating Risk of Premature Ovarian Insufficiency Using Adjunct Chinese Herbal Medicines: A Nested Patient-Control Study in Female Cancer Patients with Chemotherapy.","authors":"Tzu-Ning Tseng, Hou-Hsun Liao, Hanoch Livneh, Ming-Chi Lu, Szu-Chin Li, Tzung-Yi Tsai","doi":"10.2147/IJWH.S541702","DOIUrl":"10.2147/IJWH.S541702","url":null,"abstract":"<p><strong>Purpose: </strong>Premature ovarian insufficiency (POI) is a common late effect of chemotherapy among survivors of adolescent and young-adult cancer (AYAC). Given on the widespread use of Chinese herbal medicine (CHM) in restoring individual health, we performed a cohort-based nested patient-control study with the aim of exploring the effect of blending CHM into routine care on the reduction of chemotherapy-induced POIrisk among females with AYAC.</p><p><strong>Methods: </strong>Females aged 20-39 years with a newly-diagnosed AYAC and being free of POI between 2002 and 2010 were recruited from a population-based claims data. From these enrollees, we identified those with POI occurring after AYAC onset by the end of 2013 (n = 1040). Corresponding controls were randomly selected from the remaining subjects using a pair-matched approach. We then adopted conditional logistic regression to clarify the association between CHM use and POI risk, shown as 95% confidence intervals (CI) and adjusted odds ratios (AOR).</p><p><strong>Results: </strong>Patients who revived CHM in addition to standard treatment towards AYAC experienced a substantial lower risk of POI than did those who did not use CHM (AOR, 0.16; 95% CI, 0.13-0.19). Importantly, initiating CHM treatment within the first three years after AYAC onset had the greatest benefit, with a lower risk of POI by 92%.</p><p><strong>Conclusion: </strong>The present study revealed that embedding CHM into routine care of AYAC acted to prevent subsequent POI incident, implying that interdisciplinary collaboration and timely treatment planning should be emphasized to reduce the chance of POI onset.</p>","PeriodicalId":14356,"journal":{"name":"International Journal of Women's Health","volume":"17 ","pages":"5521-5531"},"PeriodicalIF":2.6,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12717818/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-16eCollection Date: 2025-01-01DOI: 10.2147/IJWH.S547431
Ebu Bekir Sıddık Yılmaz, Serenat Eris Yalcin
Objective: Second-trimester glycated hemoglobin (HbA1c) has been proposed as a marker of adverse pregnancy outcomes, yet its predictive value across gestational diabetes mellitus (GDM), pregestational diabetes mellitus (PGDM), and non-diabetic pregnancies remains unclear. This study assessed whether mid-pregnancy HbA1c predicts adverse perinatal outcomes and identified a clinically meaningful threshold.
Materials and methods: This retrospective cohort included 460 singleton pregnancies delivered between January 2021 and January 2025 at Bursa City Hospital. Participants were categorized as GDM (n = 203), PGDM (n = 58), or healthy controls (n = 199). HbA1c was measured at 24-28 gestational weeks. An ROC-derived cut-off of 5.3% for predicting macrosomia (>4000 g) was used for subgroup analyses. Perinatal outcomes included gestational age at delivery, delivery mode, birth weight, Apgar scores, and neonatal intensive care unit (NICU) admission. Correlation, ROC, and multivariate logistic regression analyses were performed.
Results: Median HbA1c levels were highest in the PGDM group (6.50%), followed by GDM (5.36%) and controls (4.93%) (p = 0.038). Women with HbA1c >5.3% had higher rates of preterm birth (p = 0.005), cesarean delivery (p = 0.012), and macrosomia (p = 0.004). ROC analysis showed moderate predictive ability for macrosomia (AUC = 0.642), preterm birth (AUC = 0.602), and cesarean delivery (AUC = 0.562). In multivariate analysis, maternal BMI independently predicted macrosomia (OR = 1.07; 95% CI: 1.01-1.14; p = 0.02), whereas HbA1c showed a positive but nonsignificant association (OR = 1.35; p = 0.13).
Conclusion: Second-trimester HbA1c values above 5.3% were associated with increased risks of preterm birth, cesarean delivery, and macrosomia. Although HbA1c did not independently predict adverse outcomes after adjustment, it may serve as a useful adjunct biomarker for perinatal risk stratification and could contribute to multivariable prediction models.
{"title":"Predictive Value of Second Trimester HbA1c for Adverse Perinatal Outcomes: A Comparative Study in Diabetic and Non-Diabetic Pregnancies.","authors":"Ebu Bekir Sıddık Yılmaz, Serenat Eris Yalcin","doi":"10.2147/IJWH.S547431","DOIUrl":"10.2147/IJWH.S547431","url":null,"abstract":"<p><strong>Objective: </strong>Second-trimester glycated hemoglobin (HbA1c) has been proposed as a marker of adverse pregnancy outcomes, yet its predictive value across gestational diabetes mellitus (GDM), pregestational diabetes mellitus (PGDM), and non-diabetic pregnancies remains unclear. This study assessed whether mid-pregnancy HbA1c predicts adverse perinatal outcomes and identified a clinically meaningful threshold.</p><p><strong>Materials and methods: </strong>This retrospective cohort included 460 singleton pregnancies delivered between January 2021 and January 2025 at Bursa City Hospital. Participants were categorized as GDM (n = 203), PGDM (n = 58), or healthy controls (n = 199). HbA1c was measured at 24-28 gestational weeks. An ROC-derived cut-off of 5.3% for predicting macrosomia (>4000 g) was used for subgroup analyses. Perinatal outcomes included gestational age at delivery, delivery mode, birth weight, Apgar scores, and neonatal intensive care unit (NICU) admission. Correlation, ROC, and multivariate logistic regression analyses were performed.</p><p><strong>Results: </strong>Median HbA1c levels were highest in the PGDM group (6.50%), followed by GDM (5.36%) and controls (4.93%) (p = 0.038). Women with HbA1c >5.3% had higher rates of preterm birth (p = 0.005), cesarean delivery (p = 0.012), and macrosomia (p = 0.004). ROC analysis showed moderate predictive ability for macrosomia (AUC = 0.642), preterm birth (AUC = 0.602), and cesarean delivery (AUC = 0.562). In multivariate analysis, maternal BMI independently predicted macrosomia (OR = 1.07; 95% CI: 1.01-1.14; p = 0.02), whereas HbA1c showed a positive but nonsignificant association (OR = 1.35; p = 0.13).</p><p><strong>Conclusion: </strong>Second-trimester HbA1c values above 5.3% were associated with increased risks of preterm birth, cesarean delivery, and macrosomia. Although HbA1c did not independently predict adverse outcomes after adjustment, it may serve as a useful adjunct biomarker for perinatal risk stratification and could contribute to multivariable prediction models.</p>","PeriodicalId":14356,"journal":{"name":"International Journal of Women's Health","volume":"17 ","pages":"5469-5478"},"PeriodicalIF":2.6,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12717950/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-15eCollection Date: 2025-01-01DOI: 10.2147/IJWH.S569044
Xiaoli Dong, Fang Xie, Ping Li
Background: This study investigates the relationship between the Dietary Inflammation Index (DII) and the risk of infertility among women of childbearing age in the United States.
Methods: This cross-sectional study analyzed data from 3184 women aged 20 to 45 years, utilizing information from the National Health and Nutrition Examination Survey (NHANES, 2013-2020). Dietary intake was assessed using 24-hour recall interviews to calculate the DII score, which is based on 28 dietary components. The DII score is used to assess the inflammatory potential of diet, with higher scores indicating a greater likelihood of inducing inflammation. Multivariate logistic regression and restricted cubic splines (RCS) were employed to evaluate the association between DII and infertility risk, adjusting for potential confounders such as age, BMI, and lifestyle factors. LASSO regression was used to identify key predictors, and a nomogram for predicting infertility risk was developed.
Results: Among the participants, 12.41% were classified as infertile. Women with infertility had significantly higher DII scores compared to those without infertility (2.27 [1.09, 3.14] vs 1.99 [0.92, 2.97]; p =0.016). The analysis revealed a positive association between higher DII scores and increased infertility risk, even after adjusting for confounding variables. RCS analysis indicated no significant nonlinear relationship between DII and infertility (p for non-linearity = 0.118). Furthermore, DII was identified as a more effective predictor of infertility risk than the Healthy Eating Index (HEI). The nomogram prediction model, developed from the predictive factors identified via LASSO regression, exhibited robust predictive performance, achieving an AUC of 85.1% (95% CI: 74.7%-95.5%).
Conclusion: A pro-inflammatory diet, indicated by a high Dietary Inflammatory Index (DII) score, is associated with an elevated risk of infertility in American women, thereby supporting dietary interventions to reduce inflammation for improved fertility outcomes and highlighting the relevance of dietary counseling in fertility care.
{"title":"Association of Dietary Inflammation Index with Infertility Risk in US Women: A Cross-Sectional Analysis from NHANES (2013-2020).","authors":"Xiaoli Dong, Fang Xie, Ping Li","doi":"10.2147/IJWH.S569044","DOIUrl":"10.2147/IJWH.S569044","url":null,"abstract":"<p><strong>Background: </strong>This study investigates the relationship between the Dietary Inflammation Index (DII) and the risk of infertility among women of childbearing age in the United States.</p><p><strong>Methods: </strong>This cross-sectional study analyzed data from 3184 women aged 20 to 45 years, utilizing information from the National Health and Nutrition Examination Survey (NHANES, 2013-2020). Dietary intake was assessed using 24-hour recall interviews to calculate the DII score, which is based on 28 dietary components. The DII score is used to assess the inflammatory potential of diet, with higher scores indicating a greater likelihood of inducing inflammation. Multivariate logistic regression and restricted cubic splines (RCS) were employed to evaluate the association between DII and infertility risk, adjusting for potential confounders such as age, BMI, and lifestyle factors. LASSO regression was used to identify key predictors, and a nomogram for predicting infertility risk was developed.</p><p><strong>Results: </strong>Among the participants, 12.41% were classified as infertile. Women with infertility had significantly higher DII scores compared to those without infertility (2.27 [1.09, 3.14] vs 1.99 [0.92, 2.97]; p =0.016). The analysis revealed a positive association between higher DII scores and increased infertility risk, even after adjusting for confounding variables. RCS analysis indicated no significant nonlinear relationship between DII and infertility (p for non-linearity = 0.118). Furthermore, DII was identified as a more effective predictor of infertility risk than the Healthy Eating Index (HEI). The nomogram prediction model, developed from the predictive factors identified via LASSO regression, exhibited robust predictive performance, achieving an AUC of 85.1% (95% CI: 74.7%-95.5%).</p><p><strong>Conclusion: </strong>A pro-inflammatory diet, indicated by a high Dietary Inflammatory Index (DII) score, is associated with an elevated risk of infertility in American women, thereby supporting dietary interventions to reduce inflammation for improved fertility outcomes and highlighting the relevance of dietary counseling in fertility care.</p>","PeriodicalId":14356,"journal":{"name":"International Journal of Women's Health","volume":"17 ","pages":"5453-5467"},"PeriodicalIF":2.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12716073/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-15eCollection Date: 2025-01-01DOI: 10.2147/IJWH.S560693
Guoxiu Zhang, Yihui Yang, Rugang An, Zhengquan Tan
Objective: To develop and validate a machine learning-based predictive model for assessing the risk of epidural-related maternal fever (ERMF)- a common complication during labor analgesia.
Methods: A prospective cohort study was conducted among 500 parturients with term singleton pregnancies who received epidural labor analgesia between September 2022 and August 2023. Key variables collected include maternal demographic characteristics, anesthesia-related indicators for complications, and obstetric features. Following application of exclusion criteria, 422 parturients were included and allocated into a modeling cohort (n = 337) and a validation cohort (n = 85) using stratified random sampling at an 8:2 ratio. Eleven machine learning algorithms were utilized to construct predictive models. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), area under the precision-recall curve (AUPRC), accuracy, precision, recall, and F1-score.
Results: The incidence of ERMF was 28.1% (119/422). Among the evaluated algorithms, Categorical Boosting (CatBoost) demonstrated the highest performance, with an AUC of 0.94 (95% CI: 0.86-0.98), accuracy of 90.59%, precision of 0.88, and average precision (AP) of 0.86 in the validation cohort. Analysis using SHapley Additive exPlanations (SHAP)-an interpretable artificial intelligence method- identified prolonged duration of rupture of membranes, higher maternal body mass index, and nulliparity as the top predictors of ERMF risk. An interactive web-based interface was developed to facilitate real-time clinical risk evaluation.
Conclusion: A machine learning model with high discriminative ability was constructed to predict the risk of ERMF. The CatBoost algorithm effectively identified parturients at elevated risk, and the accompanying visual tool offers evidence-based support for stratified management of intrapartum fever in clinical practice.
{"title":"Development of a Machine Learning Model to Predict Epidural-Related Maternal Fever During Labor Analgesia: A Multi-Algorithm Comparative Study with Prospective Implementation Framework.","authors":"Guoxiu Zhang, Yihui Yang, Rugang An, Zhengquan Tan","doi":"10.2147/IJWH.S560693","DOIUrl":"10.2147/IJWH.S560693","url":null,"abstract":"<p><strong>Objective: </strong>To develop and validate a machine learning-based predictive model for assessing the risk of epidural-related maternal fever (ERMF)- a common complication during labor analgesia.</p><p><strong>Methods: </strong>A prospective cohort study was conducted among 500 parturients with term singleton pregnancies who received epidural labor analgesia between September 2022 and August 2023. Key variables collected include maternal demographic characteristics, anesthesia-related indicators for complications, and obstetric features. Following application of exclusion criteria, 422 parturients were included and allocated into a modeling cohort (n = 337) and a validation cohort (n = 85) using stratified random sampling at an 8:2 ratio. Eleven machine learning algorithms were utilized to construct predictive models. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), area under the precision-recall curve (AUPRC), accuracy, precision, recall, and F1-score.</p><p><strong>Results: </strong>The incidence of ERMF was 28.1% (119/422). Among the evaluated algorithms, Categorical Boosting (CatBoost) demonstrated the highest performance, with an AUC of 0.94 (95% CI: 0.86-0.98), accuracy of 90.59%, precision of 0.88, and average precision (AP) of 0.86 in the validation cohort. Analysis using SHapley Additive exPlanations (SHAP)-an interpretable artificial intelligence method- identified prolonged duration of rupture of membranes, higher maternal body mass index, and nulliparity as the top predictors of ERMF risk. An interactive web-based interface was developed to facilitate real-time clinical risk evaluation.</p><p><strong>Conclusion: </strong>A machine learning model with high discriminative ability was constructed to predict the risk of ERMF. The CatBoost algorithm effectively identified parturients at elevated risk, and the accompanying visual tool offers evidence-based support for stratified management of intrapartum fever in clinical practice.</p>","PeriodicalId":14356,"journal":{"name":"International Journal of Women's Health","volume":"17 ","pages":"5439-5451"},"PeriodicalIF":2.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12716961/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Hypertensive disorders of pregnancy (HDP) are major causes of maternal-neonatal morbidity/mortality. Emerging evidence links early pregnancy depression to HDP, but the interaction of social support, including its potential mediating and moderating roles remains understudied. This prospective cohort study explored the associations between early pregnancy depression, social support, and HDP risk in Xuzhou, China.
Methods: A cohort of 1,406 pregnant women at ≤12weeks gestation were recruited from a hospital in Xuzhou, China, between July 2024 and July 2025. Depression symptoms and social support were assessed using the Edinburgh Postnatal Depression Scale (EPDS) and the Social Support Rating Scale (SSRS), respectively. HDP was diagnosed according to ISSHP-2021 criteria following participants until delivery. Associations were evaluated using multivariate logistic regression, mediation, and interaction analyses.
Results: Among the participants, 122 (8.6%) cases of HDP were diagnosed. After adjusting for confounders, early pregnancy depression (EPDS ≥13) significantly increased the risk of HDP (aOR = 2.63, CI: 1.67-4.09, p < 0.001). Conversely, high social support (SSRS ≥45) was a protective factor against HDP (aOR = 0.42, 95% CI: 0.20-0.85, p < 0.001). Mediation analysis further revealed that social support partially mediated the depression-HDP association, accounting for 13.6% of the total effect.
Conclusion: This prospective study demonstrates that first-trimester depressive symptoms increase the risk of HDP, and social support not only directly protects women but also partially mediates the adverse effect of depression. Our findings highlight that early psychological screening and enhancing social support during the first trimester could be crucial strategies for HDP prevention.
背景:妊娠期高血压疾病(HDP)是孕产妇-新生儿发病/死亡的主要原因。新出现的证据将妊娠早期抑郁与HDP联系起来,但社会支持的相互作用,包括其潜在的中介和调节作用仍未得到充分研究。本前瞻性队列研究探讨了中国徐州孕妇妊娠早期抑郁、社会支持和HDP风险之间的关系。方法:从2024年7月至2025年7月在中国徐州某医院招募1406名妊娠≤12周的孕妇。采用爱丁堡产后抑郁量表(EPDS)和社会支持评定量表(SSRS)分别对抑郁症状和社会支持进行评估。根据ISSHP-2021标准诊断HDP,直到分娩。使用多变量逻辑回归、中介和相互作用分析来评估关联。结果:122例(8.6%)HDP被确诊。在调整混杂因素后,妊娠早期抑郁(EPDS≥13)显著增加HDP的风险(aOR = 2.63, CI: 1.67 ~ 4.09, p < 0.001)。相反,高社会支持(SSRS≥45)是预防HDP的保护因素(aOR = 0.42, 95% CI: 0.20-0.85, p < 0.001)。进一步的中介分析显示,社会支持在抑郁与hdp的关系中起到部分中介作用,占总效应的13.6%。结论:本前瞻性研究表明,妊娠早期抑郁症状增加了HDP的风险,社会支持不仅可以直接保护妇女,还可以部分介导抑郁的不良影响。我们的研究结果强调,早期心理筛查和加强孕期前三个月的社会支持可能是预防HDP的关键策略。
{"title":"The Relationship Between Early Pregnancy Depression, Social Support, and Hypertensive Disorders of Pregnancy: A Prospective Cohort Study in Xuzhou, China.","authors":"Shiyi Chen, Nana Liu, Mingxi Yang, Zhifan Zhang, Meng Duan, Peian Wang","doi":"10.2147/IJWH.S562003","DOIUrl":"10.2147/IJWH.S562003","url":null,"abstract":"<p><strong>Background: </strong>Hypertensive disorders of pregnancy (HDP) are major causes of maternal-neonatal morbidity/mortality. Emerging evidence links early pregnancy depression to HDP, but the interaction of social support, including its potential mediating and moderating roles remains understudied. This prospective cohort study explored the associations between early pregnancy depression, social support, and HDP risk in Xuzhou, China.</p><p><strong>Methods: </strong>A cohort of 1,406 pregnant women at ≤12weeks gestation were recruited from a hospital in Xuzhou, China, between July 2024 and July 2025. Depression symptoms and social support were assessed using the Edinburgh Postnatal Depression Scale (EPDS) and the Social Support Rating Scale (SSRS), respectively. HDP was diagnosed according to ISSHP-2021 criteria following participants until delivery. Associations were evaluated using multivariate logistic regression, mediation, and interaction analyses.</p><p><strong>Results: </strong>Among the participants, 122 (8.6%) cases of HDP were diagnosed. After adjusting for confounders, early pregnancy depression (EPDS ≥13) significantly increased the risk of HDP (aOR = 2.63, CI: 1.67-4.09, p < 0.001). Conversely, high social support (SSRS ≥45) was a protective factor against HDP (aOR = 0.42, 95% CI: 0.20-0.85, p < 0.001). Mediation analysis further revealed that social support partially mediated the depression-HDP association, accounting for 13.6% of the total effect.</p><p><strong>Conclusion: </strong>This prospective study demonstrates that first-trimester depressive symptoms increase the risk of HDP, and social support not only directly protects women but also partially mediates the adverse effect of depression. Our findings highlight that early psychological screening and enhancing social support during the first trimester could be crucial strategies for HDP prevention.</p>","PeriodicalId":14356,"journal":{"name":"International Journal of Women's Health","volume":"17 ","pages":"5497-5508"},"PeriodicalIF":2.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12716959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-13eCollection Date: 2025-01-01DOI: 10.2147/IJWH.S560628
Xiaonan Wang, Baiqiang Xu, Jiayu Fan, Yanming Wang
Purpose: This study primarily aimed to identify factors influencing the knowledge, attitudes, and practices (KAP) of pregnant women regarding dental diagnosis and treatment during pregnancy in Harbin, China.
Patients and methods: A cross-sectional study was conducted from May to July 2025, during which 383 pregnant women attending the Obstetrics Department of the Fourth Affiliated Hospital of Harbin Medical University were successfully recruited via convenience sampling. A self-designed, validated questionnaire based on the KAP model and the standardized Modified Dental Anxiety Scale (MDAS) was used for data collection. Data were analyzed using descriptive statistics, Pearson correlation, univariate analysis, and multiple linear regression.
Results: The mean KAP scores (standardized to a 100-point scale) were suboptimal: knowledge, 59.36 ± 14.10; attitude, 59.92 ± 13.60; practice, 64.66 ± 16.74; and total KAP, 60.33 ± 12.28. Knowledge gaps were most evident regarding oral medications and radiographic examinations. Dental anxiety was prevalent in 72.0% of participants. The primary barrier to seeking care was safety concerns (74.93%). Medical professionals and online new media were the most frequently reported sources of oral health information. Multiple linear regression identified medical background, pregnancy intention, educational attainment, and dental anxiety as significant predictors of total KAP score (p < 0.05).
Conclusion: Pregnant women's KAP toward dental diagnosis and treatment were influenced by educational attainment, Medical professional background, pregnancy intention, and dental anxiety. Developing national guidelines, enhancing multidisciplinary collaboration, and providing targeted education and psychological support may improve oral health outcomes.
{"title":"Factors Influencing Knowledge, Attitudes, and Practices (KAP) Regarding Dental Diagnosis and Treatment During Pregnancy Among Pregnant Women in Harbin, China: A Cross-Sectional Study.","authors":"Xiaonan Wang, Baiqiang Xu, Jiayu Fan, Yanming Wang","doi":"10.2147/IJWH.S560628","DOIUrl":"10.2147/IJWH.S560628","url":null,"abstract":"<p><strong>Purpose: </strong>This study primarily aimed to identify factors influencing the knowledge, attitudes, and practices (KAP) of pregnant women regarding dental diagnosis and treatment during pregnancy in Harbin, China.</p><p><strong>Patients and methods: </strong>A cross-sectional study was conducted from May to July 2025, during which 383 pregnant women attending the Obstetrics Department of the Fourth Affiliated Hospital of Harbin Medical University were successfully recruited via convenience sampling. A self-designed, validated questionnaire based on the KAP model and the standardized Modified Dental Anxiety Scale (MDAS) was used for data collection. Data were analyzed using descriptive statistics, Pearson correlation, univariate analysis, and multiple linear regression.</p><p><strong>Results: </strong>The mean KAP scores (standardized to a 100-point scale) were suboptimal: knowledge, 59.36 ± 14.10; attitude, 59.92 ± 13.60; practice, 64.66 ± 16.74; and total KAP, 60.33 ± 12.28. Knowledge gaps were most evident regarding oral medications and radiographic examinations. Dental anxiety was prevalent in 72.0% of participants. The primary barrier to seeking care was safety concerns (74.93%). Medical professionals and online new media were the most frequently reported sources of oral health information. Multiple linear regression identified medical background, pregnancy intention, educational attainment, and dental anxiety as significant predictors of total KAP score (<i>p</i> < 0.05).</p><p><strong>Conclusion: </strong>Pregnant women's KAP toward dental diagnosis and treatment were influenced by educational attainment, Medical professional background, pregnancy intention, and dental anxiety. Developing national guidelines, enhancing multidisciplinary collaboration, and providing targeted education and psychological support may improve oral health outcomes.</p>","PeriodicalId":14356,"journal":{"name":"International Journal of Women's Health","volume":"17 ","pages":"5399-5410"},"PeriodicalIF":2.6,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12713654/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Menopause characterized by estrogen deficiency and has various symptoms, including vasomotor, genitourinary, and psychological manifestations. Innovative drug delivery systems (IDDSs) offer targeted approaches that increase therapeutic efficacy, reduce side effects, and improve patient adherence. To update our knowledge about Drug Delivery Systems (DDS) for decrease menopausal symptoms and its benefits compare with conventional systems. This review systematically examines the application and clinical potential of IDDS for managing menopause-related symptoms, with a particular emphasis on improvements in efficacy, safety, and patient adherence. A comprehensive literature search across multiple databases (PubMed, Em-base, Cochran, Scopus; 2001-2024) yielded 23 studies, including RCTs and observational studies on trans dermal, intravaginal, and Nano-based DDS s (patches, vaginal rings, nano particles) and Neurokinin-3 (NK3) antagonists. Transdermal systems, such as estrogen patches, maintained stable hormone levels and reduced thromboembolism risk by 30% compared to oral hormone replacement therapy (HRT), by bypassing first-pass metabolism. Intravaginal DDS s, like estradiol rings, relieved genitourinary symptoms with less than 1% systemic absorption, thereby minimizing endometrial risks. Non-hormonal Neurokini3 antagonists like fezolinetant, decreased VMS by 60% and benefited high-risk patients. Emerging technologies, like hydro gels, showed preclinical potential but lack long-term safety data. Adherence to treatment was better with sustained-release formulations, such as pellet implants, compared to daily dosing regimens. DDSs offer personalized menopause management, balancing safety and efficacy. Future research should focus on pharmacogenomics, equity, and long-term safety of advanced DDSs, especially those using nanotechnology.
{"title":"Innovative Drug Delivery Systems for Management of Menopausal Symptoms: A Systematic Review.","authors":"Zahra Bostani Khalesi, Mahmood Abedinzade, Mostafa Golshekan","doi":"10.2147/IJWH.S557866","DOIUrl":"10.2147/IJWH.S557866","url":null,"abstract":"<p><p>Menopause characterized by estrogen deficiency and has various symptoms, including vasomotor, genitourinary, and psychological manifestations. Innovative drug delivery systems (IDDSs) offer targeted approaches that increase therapeutic efficacy, reduce side effects, and improve patient adherence. To update our knowledge about Drug Delivery Systems (DDS) for decrease menopausal symptoms and its benefits compare with conventional systems. This review systematically examines the application and clinical potential of IDDS for managing menopause-related symptoms, with a particular emphasis on improvements in efficacy, safety, and patient adherence. A comprehensive literature search across multiple databases (PubMed, Em-base, Cochran, Scopus; 2001-2024) yielded 23 studies, including RCTs and observational studies on trans dermal, intravaginal, and Nano-based DDS s (patches, vaginal rings, nano particles) and Neurokinin-3 (NK3) antagonists. Transdermal systems, such as estrogen patches, maintained stable hormone levels and reduced thromboembolism risk by 30% compared to oral hormone replacement therapy (HRT), by bypassing first-pass metabolism. Intravaginal DDS s, like estradiol rings, relieved genitourinary symptoms with less than 1% systemic absorption, thereby minimizing endometrial risks. Non-hormonal Neurokini3 antagonists like fezolinetant, decreased VMS by 60% and benefited high-risk patients. Emerging technologies, like hydro gels, showed preclinical potential but lack long-term safety data. Adherence to treatment was better with sustained-release formulations, such as pellet implants, compared to daily dosing regimens. DDSs offer personalized menopause management, balancing safety and efficacy. Future research should focus on pharmacogenomics, equity, and long-term safety of advanced DDSs, especially those using nanotechnology.</p>","PeriodicalId":14356,"journal":{"name":"International Journal of Women's Health","volume":"17 ","pages":"5425-5438"},"PeriodicalIF":2.6,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12712845/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-13eCollection Date: 2025-01-01DOI: 10.2147/IJWH.S567928
Sijia Huang, Xueyan Cao, Yuling Xu, Juan Zhu, Min Su
Objective: The CXCL16/CXCR6 signaling pathway is implicated in macrophage polarization. The correlation between CXCL16 and CXCR6 expressions in decidual tissues from patients with preeclampsia (PE) and macrophage polarization remains unexplored. This study aimed to investigate the correlation between the chemokine axis CXCL16/CXCR6 and macrophage polarization at the maternal-fetal interface in PE.
Methods: In this study, macrophage polarization status in the decidua was assessed using Western blotting (WB), immunohistochemistry (IHC), and immunofluorescence (IF) staining. For quantitative characterization, primary decidual macrophages were isolated and subjected to flow cytometry analysis to further evaluate macrophage polarization. Expression of CXCL16 and CXCR6 in decidual tissues was evaluated by WB and IHC. Additionally, the expressions of CXCL16 and CXCR6 in decidual macrophages were assessed by immunofluorescence double staining.
Results: IHC and WB demonstrated a significant upregulation of CD86 (P < 0.05), alongside a downregulation of CXCL16, CXCR6, and CD206 (P < 0.01) in PE decidual tissues. IF double staining revealed an increased abundance of CD68⁺CD80⁺/CD86⁺ cells in the decidua of patients with PE, while CD68⁺CD163⁺/CD206⁺ and CD68⁺CXCL16⁺/CXCR6⁺ cells was decreased. Flow cytometry analysis of primary decidual macrophages isolated from PE patients confirmed an increase in the proportions of CD68⁺CD80⁺ (P < 0.01) and CD68⁺CD86⁺ (P < 0.0001), and a marked decrease in CD68⁺CD163⁺ (P< 0.001) and CD68⁺CD206⁺ (P < 0.0001). These results indicate dysregulated decidual macrophage polarization in PE, characterized by an M1 bias that may be mediated by impaired CXCL16/CXCR6 signaling at the maternal-fetal interface.
{"title":"Altered Expression of CXCL16/CXCR6 and Its Correlation with Decidual Macrophage Polarization in Preeclampsia.","authors":"Sijia Huang, Xueyan Cao, Yuling Xu, Juan Zhu, Min Su","doi":"10.2147/IJWH.S567928","DOIUrl":"10.2147/IJWH.S567928","url":null,"abstract":"<p><strong>Objective: </strong>The CXCL16/CXCR6 signaling pathway is implicated in macrophage polarization. The correlation between CXCL16 and CXCR6 expressions in decidual tissues from patients with preeclampsia (PE) and macrophage polarization remains unexplored. This study aimed to investigate the correlation between the chemokine axis CXCL16/CXCR6 and macrophage polarization at the maternal-fetal interface in PE.</p><p><strong>Methods: </strong>In this study, macrophage polarization status in the decidua was assessed using Western blotting (WB), immunohistochemistry (IHC), and immunofluorescence (IF) staining. For quantitative characterization, primary decidual macrophages were isolated and subjected to flow cytometry analysis to further evaluate macrophage polarization. Expression of CXCL16 and CXCR6 in decidual tissues was evaluated by WB and IHC. Additionally, the expressions of CXCL16 and CXCR6 in decidual macrophages were assessed by immunofluorescence double staining.</p><p><strong>Results: </strong>IHC and WB demonstrated a significant upregulation of CD86 (P < 0.05), alongside a downregulation of CXCL16, CXCR6, and CD206 (P < 0.01) in PE decidual tissues. IF double staining revealed an increased abundance of CD68⁺CD80⁺/CD86⁺ cells in the decidua of patients with PE, while CD68⁺CD163⁺/CD206⁺ and CD68⁺CXCL16⁺/CXCR6⁺ cells was decreased. Flow cytometry analysis of primary decidual macrophages isolated from PE patients confirmed an increase in the proportions of CD68⁺CD80⁺ (P < 0.01) and CD68⁺CD86⁺ (P < 0.0001), and a marked decrease in CD68⁺CD163⁺ (P< 0.001) and CD68⁺CD206⁺ (P < 0.0001). These results indicate dysregulated decidual macrophage polarization in PE, characterized by an M1 bias that may be mediated by impaired CXCL16/CXCR6 signaling at the maternal-fetal interface.</p>","PeriodicalId":14356,"journal":{"name":"International Journal of Women's Health","volume":"17 ","pages":"5411-5423"},"PeriodicalIF":2.6,"publicationDate":"2025-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12714541/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145804345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-12eCollection Date: 2025-01-01DOI: 10.2147/IJWH.S565574
Na Shi, Shuhua Ji, Yan Zhang, Huiling Qu, Jinwei Hou, Longhuan Jiang, Hai-Ping Liu
Background: The association between PCOS and the TCM concept of phlegm-damp constitution is well-documented, but their connection via miRNA remains unclear. This study sought to identify key miRNAs implicated in the transition from phlegm-damp constitution to PCOS and to elucidate their associated regulatory networks.
Methods: We conducted miRNA sequencing on granulosa cells from three groups: healthy controls with a neutral constitution (NP), healthy individuals with a phlegm-damp constitution (NB), and PCOS patients (PC). Principal component analysis (PCA) and differential expression analysis were utilized to pinpoint candidate miRNAs, which were subsequently validated using quantitative real-time PCR (qRT-PCR) in larger cohorts. Bioinformatics, including target prediction, protein-protein interaction (PPI) network construction, and pathway analysis, were employed to delineate the regulatory networks involved.
Results: PCA revealed distinct clustering patterns, with NB and PC groups exhibiting closer proximity compared to the NP group. Differential expression analysis identified 24 dysregulated miRNAs in the PC group (20 upregulated, 4 downregulated) and 14 in the NB group (11 upregulated, 3 downregulated), with both groups showing shared enrichment in metabolic, PI3K-Akt, and Ras pathways. Validation confirmed a progressive downregulation of hsa-miR-24-2-5p and hsa-miR-33a-5p across the NP, the NB, and PC groups (P<0.05), whereas hsa-miR-374b-5p exhibited differential expression exclusively between NB and PC groups. Network analysis identified five hub genes (EGFR, MYC, KRAS, CREB1, SMAD4) and nine risk pathways, including MAPK and Wnt signaling pathways. The constructed miRNA-hub gene-pathway network comprised five miRNA-hub gene pairs and thirteen functional modules.
Conclusion: These findings elucidate shared miRNA regulatory mechanisms between phlegm-damp constitution and PCOS, highlighting hsa-miR-24-2-5p and hsa-miR-33a-5p as pivotal mediators in this pathological transition. This provides molecular evidence for the TCM "constitution-disease correlation" theory and identifies potential targets for the prevention and treatment of PCOS.
{"title":"From Constitution to Disease: MicroRNA Signatures for the Early Prediction and Targeted Prevention of Polycystic Ovary Syndrome.","authors":"Na Shi, Shuhua Ji, Yan Zhang, Huiling Qu, Jinwei Hou, Longhuan Jiang, Hai-Ping Liu","doi":"10.2147/IJWH.S565574","DOIUrl":"10.2147/IJWH.S565574","url":null,"abstract":"<p><strong>Background: </strong>The association between PCOS and the TCM concept of phlegm-damp constitution is well-documented, but their connection via miRNA remains unclear. This study sought to identify key miRNAs implicated in the transition from phlegm-damp constitution to PCOS and to elucidate their associated regulatory networks.</p><p><strong>Methods: </strong>We conducted miRNA sequencing on granulosa cells from three groups: healthy controls with a neutral constitution (NP), healthy individuals with a phlegm-damp constitution (NB), and PCOS patients (PC). Principal component analysis (PCA) and differential expression analysis were utilized to pinpoint candidate miRNAs, which were subsequently validated using quantitative real-time PCR (qRT-PCR) in larger cohorts. Bioinformatics, including target prediction, protein-protein interaction (PPI) network construction, and pathway analysis, were employed to delineate the regulatory networks involved.</p><p><strong>Results: </strong>PCA revealed distinct clustering patterns, with NB and PC groups exhibiting closer proximity compared to the NP group. Differential expression analysis identified 24 dysregulated miRNAs in the PC group (20 upregulated, 4 downregulated) and 14 in the NB group (11 upregulated, 3 downregulated), with both groups showing shared enrichment in metabolic, PI3K-Akt, and Ras pathways. Validation confirmed a progressive downregulation of hsa-miR-24-2-5p and hsa-miR-33a-5p across the NP, the NB, and PC groups (P<0.05), whereas hsa-miR-374b-5p exhibited differential expression exclusively between NB and PC groups. Network analysis identified five hub genes (<i>EGFR, MYC, KRAS, CREB1, SMAD4</i>) and nine risk pathways, including MAPK and Wnt signaling pathways. The constructed miRNA-hub gene-pathway network comprised five miRNA-hub gene pairs and thirteen functional modules.</p><p><strong>Conclusion: </strong>These findings elucidate shared miRNA regulatory mechanisms between phlegm-damp constitution and PCOS, highlighting hsa-miR-24-2-5p and hsa-miR-33a-5p as pivotal mediators in this pathological transition. This provides molecular evidence for the TCM \"constitution-disease correlation\" theory and identifies potential targets for the prevention and treatment of PCOS.</p>","PeriodicalId":14356,"journal":{"name":"International Journal of Women's Health","volume":"17 ","pages":"5389-5398"},"PeriodicalIF":2.6,"publicationDate":"2025-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12707243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145774552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}